Bryan Roberts - Achaogen Chairman of the Board

Chairman

Dr. Bryan E. Roberts, Ph.D., is Independent Chairman of the Board of the Company. Dr. Roberts joined Venrock, a VC investment firm, in 1997, where he currently serves as Partner. From 1989 to 1992, Dr. Roberts worked in the corporate finance department of Kidder, Peabody Co., a brokerage company. Dr. Roberts also currently serves as the chairman of the board of Castlight as well as a chairman and director of several private companies. Dr. Roberts previously served on the board of directors of publicly traded Athenahealth, Inc. from 1999 to 2009, XenoPort, Inc., from 2000 to 2007, Sirna Therapeutics, Inc. from 2003 to 2007, Vitae Pharmaceuticals, Inc. from 2001 to 2016, Zeltiq Aethetics, Inc. from 2008 to 2016 and Ironwood Pharmaceuticals, Inc. from 2001 to 2016 since 2009.
Age 50
Tenure 15 years
Professional MarksPh.D
Phone650 800-3636
Webwww.achaogen.com
Roberts holds a B.A. in Chemistry from Dartmouth College and a Ph.D. in Chemistry and Chemical Biology from Harvard University.

Achaogen Management Efficiency

Achaogen's management efficiency ratios could be used to measure how well Achaogen manages its routine affairs as well as how well it operates its assets and liabilities.
The company currently holds 49.78 M in liabilities with Debt to Equity (D/E) ratio of 99.9, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Achaogen has a current ratio of 0.76, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Achaogen until it has trouble settling it off, either with new capital or with free cash flow. So, Achaogen's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Achaogen sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Achaogen to invest in growth at high rates of return. When we think about Achaogen's use of debt, we should always consider it together with cash and equity.

Similar Executives

Found 8 records

CHAIRMAN Age

Charles ChaoWeibo Corp
51
Harvey BlauGriffon
82
Or AlovitzSpace Communication
35
Ronald KramerGriffon
66
Richard MuellerGMS Inc
77
John GavinGMS Inc
64
Howard LanceSummit Materials
65
Bernard AldrichApogee Enterprises
67
Achaogen, Inc., a biopharmaceutical company, focuses on the development and commercialization of antibacterial agents for multi-drug resistant gram-negative infections in the United States. On April 15, 2019, Achaogen, Inc. filed a voluntary petition for reorganization under Chapter 11 in the U.S. Achaogen operates under Biotechnology classification in USA and is traded on BATS Exchange. It employs 42 people. Achaogen (AKAO) is traded on NASDAQ Exchange in USA and employs 42 people.

Management Performance

Achaogen Leadership Team

Elected by the shareholders, the Achaogen's board of directors comprises two types of representatives: Achaogen inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Achaogen. The board's role is to monitor Achaogen's management team and ensure that shareholders' interests are well served. Achaogen's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Achaogen's outside directors are responsible for providing unbiased perspectives on the board's policies.
Janet Dorling, Chief Commercial Officer
Paal Johnsen, Executive Vice President - Investment Director
Christopher Walsh, Independent Director
Ian Friedland, Chief Medical Officer
Liz Bhatt, COO
Gary Loeb, General Counsel
Sarah Ryan, Director
Leif Borge, CFO
Zeryn Sarpangal, Principal Financial Officer, Principal Accounting Officer and VP of HR and Corporate Affairs
Halley Gilbert, Director
John Smither, Independent Director
Lee Swem, Senior Vice President Chief Scientific Officer
Stian Sjolund, Director, Employee Representative
Blake Wise, COO
Gregory Stea, Director
Tobin Schilke, CFO, Principal Financial Officer and Principal Accounting Officer
Kent Lieginger, Director
Elizabeth Bhatt, COO
Asle Halvorsen, Director, Employee Representative
Kristian Rokke, Chairman of the Board
Alan Colowick, Director
John Doyle, Director
Oyvind Eriksen, Director
Kenneth Hillan, President CEO, Chief Medical Officer, Director
Lone Schroder, Deputy Chairman of the Board
Henning Jensen, Director, Employee Representative
Michael Fischbach, Director
Karen Bernstein, Independent Director
Karl Kjelstad, CEO
Bryan Roberts, Chairman of the Board
Kathryn Baker, Director

Achaogen Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Achaogen a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Achaogen in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Achaogen's short interest history, or implied volatility extrapolated from Achaogen options trading.

Pair Trading with Achaogen

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Achaogen position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Achaogen will appreciate offsetting losses from the drop in the long position's value.
The ability to find closely correlated positions to Ross Stores could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Ross Stores when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Ross Stores - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Ross Stores to buy it.
The correlation of Ross Stores is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Ross Stores moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Ross Stores moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Ross Stores can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation.
Note that the Achaogen information on this page should be used as a complementary analysis to other Achaogen's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.

Other Consideration for investing in Achaogen Stock

If you are still planning to invest in Achaogen check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Achaogen's history and understand the potential risks before investing.
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Transaction History
View history of all your transactions and understand their impact on performance
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes